Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2436-2443

  Reiff, Andreas ^a,f   Rawlings, David J ^a   Shaham, Bracha ^a   Franke, Elisabeth ^b   Richardson, Lisa ^c   Szer, Ilona S ^d   Bernstein, Bram H ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e USC School of Medicine

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Corticosteroids; Cyclosporin A; Juvenile dermatomyositis; Juvenile rheumatoid arthritis; Methotrexate

Indexed keywords

CREATINE KINASE; CYCLOSPORIN A; METHOTREXATE; PREDNISONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; MORNING STIFFNESS; MUSCLE STRENGTH; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; METHOTREXATE; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 0031452021     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Faulds D, Goa KL, Benfield P: Cyclosporine A; review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
2. Kahan BD: Cyclosporine. N Engl J Med 1989;321:1725-37.
3. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporine A and FK506. Immunology Today 1992;13:136-42.
4. Russel RG, Graveley R, Skjodt H: The effects of cyclosporine A on bone and cartilage. Br J Rheumatol 1993;32:42-6.
5. Tugwell P, Baker P: Guidelines for the use of cyclosporine in rheumatoid arthritis. Clin Rheumatol 1995;(suppl 2)14:37-41.
6. Richardson C, Emery P: Clinical use of cyclosporine in rheumatoid arthritis. Drugs 1995;(suppl 1)50:26-36.
7. Dijkmans BAC, van Rijthoven AWAM, Goei The HS, Boers M, Cats A: Cyclosporine in rheumatoid arthritis. Semin Arthritis Rheum 1992;1:30-6.
8. Ostensen M, Hoyeraal HM, Kass E: Tolerance of cyclosporine A in children with refractory juvenile chronic arthritis. J Rheumatol 1988;15:1536-8.
9. Pistoia V, Buoncompagni A, Scribanis R, et al: Cyclosporine A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol 1992;11:203-8.
10. Fantini F: Cyclosporine therapy in systemic juvenile rheumatoid arthritis (Still's disease): An open pilot prospective study. Cyclosporine in Autoimmune Diseases. Milan: Il Pensiero Scientifico Editore, 1993:133-42.
11. Zeller V, Cohen P, Prieur A-M, Guillevin L: Cyclosporine A therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J Rheumatol 1996;23:1424-7.
12. Grau JM, Herrero C, Casademont J, Fernandez-Sola J, Urbano-Marquez A: Cyclosporine A as first choice therapy for dermatomyositis (letter). J Rheumatol 1994;21:381-2.
13. Mehregan DR, Su WP: Cyclosporine treatment for dermatomyositis/polymyositis. Cutis 1993;51:59-61.
14. Leuck CJ, Trend P, Swash M: Cyclosporine in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psych 1991;54:1007-8.
15. Dantzig P: Juvenile dermatomyositis treated with cyclosporine. J Am Acad Dermatol 1990;22:310-1.
16. Girardin E, Dayer JM, Paunier L: Cyclosporine for juvenile dermatomyositis. J Pediatr 1988;112:165-6.
17. Brahn E, Peacock DJ, Banquerigo ML: Suppression of collagen induced arthritis by combination cyclosporine A and methotrexate therapy. Arthritis Rheum 1991;34:1282-7.
18. Bensen W, Tugwell P, Roberts RM, et al: Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies). J Rheumatol 1994;21:2034-8.
19. Tugwell P, Pincus T, Yocum DE, et al: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
20. Yocum DE: Combination therapy with cyclosporine in rheumatoid arthritis. Drugs 1995;(suppl 1)50:37-40.
21. Jacobs JC: Pediatric Rheumatology for the Practitioner, 2nd ed. New York: Springer-Verlag, 1982.
22. Reiff A, Shaham G, Wood BP, Bernstein B, Stanley P, Szer IS: High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol 1995;13:113-8.
23. Dawson T, Ryan PF, Findeisen JM, Scheinkestel CD: Pneumocystis carinii pneumonia following cyclosporine A and methotrexate treated rheumatoid arthritis (letter). J Rheumatol 1992;19:997.
24. Starzl TE, Nalesnik MA, Porter KA, et al: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984;1:583-7.
25. Ferraccioli GF, Casatta L, Bartoli E, et al: Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporine A. Arthritis Rheum 1995;38:867-8.
26. Kamel OW, Van De Rijn M, Weiss LM, et al: Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328:1317-21.
27. Tugwell P, Bombardier C, Gent M, et al: Low-dose cyclosporine in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
28. Boers M, Dijkmans BAC, van Rijthoven AWAM, Goei Thè HS, Cats A: Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. J Rheumatol 1990;17:38-42.
29. Landewe RB, Goei The HS, van Rijthoven AW, Rietveld JR, Breedveld FC, Dijkmans BA: Cyclosporine in common clinical practice: An estimation of the benefit/risk ratio in patients with rheumatoid arthritis. J Rheumatol 1994;21:1631-6.
30. Feutren G, Mihatsch MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
31. Dougados M, Duchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low dose cyclosporine in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:550-6.
32. Weinblatt ME, Coblyn JS, Fraser A, et al: Cyclosporine A treatment of refractory rheumatoid arthritis. Arthritis Rheum 1987;30:11-7.
33. Altmann RD, Perez GO, Sfakianakis GN: Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med 1992;93:396-9.
34. Forre O: Radiologie evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48 week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Arthritis Rheum 1994;37:1506-12.